Literature DB >> 16815154

Role of vasculature in atopic dermatitis.

Martin Steinhoff1, Antje Steinhoff, Bernhard Homey, Thomas A Luger, Stefan W Schneider.   

Abstract

Atopic dermatitis (AD) lesions are characterized by differences in the activation state of endothelial cells and vascular smooth muscle cells and the release of inflammatory mediators by and toward the vasculature. The vascular system, including endothelial cells and smooth muscle cells, is ultimately involved in clinical symptoms of AD, such as erythema, edema, leukocyte recruitment, and white dermographism. Various mediators and bidirectional neurovascular interactions regulate the inflammatory response during AD. T cell-endothelial cell interactions are a crucial component to establish acute AD. Various immune cells, including monocytes and mast cells, communicate with the endothelium by releasing inflammatory mediators, thereby stimulating inflammatory mediator release from activated endothelial cells. The process of adhesion, tethering, and transmigration of infiltrating cells is a highly regulated and an active communication process between endothelial cells and leukocytes. Endothelial cells play a pivotal role in the pathophysiology of AD and represent future targets for the treatment of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815154     DOI: 10.1016/j.jaci.2006.04.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Clinical significance of serum vascular endothelial-cadherin levels in inflammatory skin diseases.

Authors:  Haruka Kuriyama; Masatoshi Jinnin; Hisashi Kanemaru; Asako Ichihara; Akihiko Fujisawa; Chikako Moriya; Satoshi Fukushima; Hironobu Ihn
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

2.  Single-cell transcriptome profile of mouse skin undergoing antigen-driven allergic inflammation recapitulates findings in atopic dermatitis skin lesions.

Authors:  Juan Manuel Leyva-Castillo; Liang Sun; Shih-Ying Wu; Shira Rockowitz; Piotr Sliz; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2022-03-15       Impact factor: 14.290

3.  Biological properties of mud extracts derived from various spa resorts.

Authors:  Eliana Spilioti; Margarita Vargiami; Sophia Letsiou; Konstantinos Gardikis; Varvara Sygouni; Petros Koutsoukos; Ioanna Chinou; Eva Kassi; Paraskevi Moutsatsou
Journal:  Environ Geochem Health       Date:  2016-07-21       Impact factor: 4.609

4.  Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses.

Authors:  Lam C Tsoi; Elke Rodriguez; Dora Stölzl; Ulrike Wehkamp; Jingru Sun; Sascha Gerdes; Mrinal K Sarkar; Matthias Hübenthal; Chang Zeng; Ranjitha Uppala; Xianying Xing; Frederieke Thielking; Allison C Billi; William R Swindell; Alanna Shefler; Jiahan Chen; Matthew T Patrick; Paul W Harms; J Michelle Kahlenberg; Bethany E Perez White; Emanual Maverakis; Johann E Gudjonsson; Stephan Weidinger
Journal:  J Allergy Clin Immunol       Date:  2019-12-28       Impact factor: 10.793

5.  Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography.

Authors:  Robert A Byers; Raman Maiti; Simon G Danby; Elaine J Pang; Bethany Mitchell; Matt J Carré; Roger Lewis; Michael J Cork; Stephen J Matcher
Journal:  Biomed Opt Express       Date:  2018-03-29       Impact factor: 3.732

Review 6.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 7.  Efficacy of kampo medicine in treating atopic dermatitis: an overview.

Authors:  Tadamichi Shimizu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-29       Impact factor: 2.629

8.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

9.  Effectiveness of keishibukuryogan on chronic-stage lichenification associated with atopic dermatitis.

Authors:  Megumi Mizawa; Teruhiko Makino; Hiroaki Hikiami; Yutaka Shimada; Tadamichi Shimizu
Journal:  ISRN Dermatol       Date:  2012-11-14

10.  Traditional Chinese Medicine Decreases the Stroke Risk of Systemic Corticosteroid Treatment in Dermatitis: A Nationwide Population-Based Study.

Authors:  Kao-Sung Tsai; Chia-Sung Yen; Po-Yuan Wu; Jen-Huai Chiang; Jui-Lung Shen; Chung-Hsien Yang; Huey-Yi Chen; Yung-Hsiang Chen; Wen-Chi Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.